3rd Quarter - Report

BROWNSTEIN HYATT FARBER SCHRECK, LLP for FERRING PHARMACEUTICALS INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to microbiome, oncology, & fertility Issues related to formulary tier status Drug pricing policy Healthcare policy in the NDAA IVF Tax credit FDA Review programs

Foreign entity interest: Ferring Holdings SA and Ferring BV listed on the registration under foreign entities have an interest in healthcare policy as the ultimate parent company.

LobbyistCovered position, as disclosed
EMILY FELDER —
HAROLD HANCOCK —
STEPHEN HOLLAND New Senior Health Counsel, Health Counsel - House Energy and Commerce Committee (Rep. Frank Pallone); Counsel, Legislative Assistant - Rep. Kurt Schrader
SARA MORSE New Principal Deputy Assistant Secretary for Legislation at the Department of Health and Human Services; Deputy Assistant Secretary for Legislation at the Department of Health and Human Services
DAVID REID —
TIM SHADYAC —
ADAM STEINMETZ —
RUSSELL W. SULLIVAN —
DEEMA TARAZI —
JONATHAN TOWERS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Veterans VET

Issues related to veteran's care and veteran's reproductive care

Foreign entity interest: Ferring Holdings SA and Ferring BV listed on the registration under foreign entities have an interest in veteran's care.

LobbyistCovered position, as disclosed
JONATHAN TOWERS —

Trade (domestic/foreign) TRD

Issues related to pharmaceutical tariffs

Foreign entity interest: Ferring Holdings SA and Ferring BV listed on the registration under foreign entities have an interest in pharmaceutical tariffs.

LobbyistCovered position, as disclosed
AARON CUMMINGS —
EMILY FELDER —
JOSEPH BRADY HOWELL —
TIM SHADYAC —

Contacted: Commerce, Dept of (DOC)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.